Eversept Partners LP lowered its position in shares of Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Rating) by 82.3% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 830,960 shares of the company’s stock after selling 3,859,852 shares during the quarter. Eversept Partners LP owned […]
Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Rating)’s share price rose 4.2% on Friday . The stock traded as high as $2.50 and last traded at $2.50. Approximately 337,571 shares changed hands during mid-day trading, a decline of 66% from the average daily volume of 994,809 shares. The stock had previously closed at $2.40. Analyst Upgrades […]
Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Rating)’s share price was up 6.6% on Tuesday . The company traded as high as $2.42 and last traded at $2.42. Approximately 654,116 shares changed hands during mid-day trading, a decline of 33% from the average daily volume of 982,323 shares. The stock had previously closed at $2.27. Wall […]
Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Rating)’s share price was up 6.6% on Tuesday . The company traded as high as $2.42 and last traded at $2.42. Approximately 654,116 shares changed hands during mid-day trading, a decline of 33% from the average daily volume of 982,323 shares. The stock had previously closed at $2.27. Wall […]
Shares of Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Rating) have received an average rating of “Moderate Buy” from the eight brokerages that are presently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average twelve-month price […]